Oscar Health Inc. (OSCR) Tops Q3 EPS by 20c

Oscar Health Inc. (NYSE: OSCR) reported Q3 EPS of ($0.29), $0.20 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $1.43 billion versus the consensus estimate of $1.41 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)